Table 3.
Three-year overall survival and disease-free survival for all patients
| Characteristics | (n) | % 3-year OS | P-value | % 3-year DFS | P-value |
|---|---|---|---|---|---|
| Age in years | |||||
| <75 | 46 | 74.4 | 0.658 | 51.5 | 0.500 |
| ≥75 | 20 | 80.1 | 56.6 | ||
| Sex | |||||
| Male | 44 | 72.8 | 0.445 | 55.3 | 0.903 |
| Female | 22 | 82.0 | 51.4 | ||
| PS | |||||
| PS0 | 48 | 74.9 | 0.955 | 56.2 | 0.257 |
| PS1-2 | 18 | 80.7 | 46.5 | ||
| Number of targets | |||||
| 1 | 56 | 77.8 | 0.599 | 54.1 | 0.748 |
| 2 | 10 | 57.1 | 53.3 | ||
| Primary lesion | |||||
| Colorectal | 13 | 60.6 | 0.932 | 0 | 0.046 |
| Others | 53 | 76.6 | 61.4 | ||
| Histologic type of primary lesion | |||||
| Adenocarcinoma | 45 | 79.8 | 0.315 | 51.7 | 0.993 |
| SCC | 21 | 65.1 | 59.6 | ||
| DFI in months | |||||
| ≤30 | 31 | 62.2 | 0.030 | 40.4 | 0.111 |
| >30 | 35 | 85.2 | 64.4 |
DFI = disease-free interval, PS = performance status, SCC = squamous cell carcinoma.